2017
DOI: 10.1148/radiol.2017161127
|View full text |Cite
|
Sign up to set email alerts
|

Familial Cerebral Cavernous Malformations Are Associated with Adrenal Calcifications on CT Scans: An Imaging Biomarker for a Hereditary Cerebrovascular Condition

Abstract: Purpose To determine if adrenal calcifications seen at computed tomography (CT) are associated with familial cerebral cavernous malformations (fCCMs) in carriers of the CCM1 Common Hispanic Mutation. Materials and Methods This study was approved by the institutional review board. The authors retrospectively reviewed abdominal CT scans in 38 patients with fCCM, 38 unaffected age- and sex-matched control subjects, and 13 patients with sporadic, nonfamilial cerebral cavernous malformation (CCM). The size, numbe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…A recent study found small focal calcifications (SFCs) in the adrenal glands identified on computed tomography scans to be common in FCCM patients. 57 These SFCs were found to be more common in the left adrenal gland, and FCCM patients with SFCs had significantly more brain lesions than did those without SFCs ( P <0.001). It is suggested that these SFCs might be a clinically silent manifestation of disease and can be used as an imaging biomarker in FCCM patients.…”
Section: Recent Update On Research Approaches Molecular Pathogenesismentioning
confidence: 81%
See 1 more Smart Citation
“…A recent study found small focal calcifications (SFCs) in the adrenal glands identified on computed tomography scans to be common in FCCM patients. 57 These SFCs were found to be more common in the left adrenal gland, and FCCM patients with SFCs had significantly more brain lesions than did those without SFCs ( P <0.001). It is suggested that these SFCs might be a clinically silent manifestation of disease and can be used as an imaging biomarker in FCCM patients.…”
Section: Recent Update On Research Approaches Molecular Pathogenesismentioning
confidence: 81%
“…It is suggested that these SFCs might be a clinically silent manifestation of disease and can be used as an imaging biomarker in FCCM patients. 57…”
Section: Recent Update On Research Approaches Molecular Pathogenesismentioning
confidence: 99%
“…Cavernous malformations in the brain are usually multiple, sometimes numbering in the hundreds. Vascular lesions in the retina in approximately 5% and in the skin in 20% of patients have also been reported [1][2][3], as have small adrenal calcifications [4]. The question of skeletal involvement is complicated by the common occurrence of intraosseous vascular malformations, commonly referred to as vertebral hemangiomas, in the general population, prompting us to include a matched control group.…”
Section: Discussionmentioning
confidence: 99%
“…This disorder, which is characterized primarily by formation and growth of cavernous malformations within the brain and spinal cord, is recognized as a multisystem neurocutaneous disorder. Vascular lesions can be found in the retina, adrenal glands, and skin of patients with FCCM [1][2][3][4]. Scattered reports exist of intraosseous vascular malformations, commonly referred to as vertebral hemangiomas, in these patients, with a presumed shared cause of the intraosseous and CNS lesions.…”
mentioning
confidence: 99%
“…The majority of cavernous malformations in FCCM are found in the central nervous system (CNS), where they are prone to thrombosis, growth, and hemorrhage (Tomlinson et al, ). Extraneural cavernomas, which occur more frequently with the inherited variant of the disease, have been noted in the retina, liver, adrenal glands, and skin (Campione et al, ; Haghighi, Fathi, Shahbazi, Motahari, & Friedman, ; Sirvente, Enjolras, Wassef, Tournier‐Lasserve, & Labauge, ; Strickland et al, ; Toll & Parera, ). Some cutaneous cavernomas have been shown share similar histology and identical gene mutations to their CCM counterparts (Eerola, Parera, & Gimenez‐Arnau, ).…”
Section: Introductionmentioning
confidence: 99%